Company attributes
Industry
Location
Founder
Pitchbook URL
Subsidiary
Investors
Founded Date
2019
Total Funding Amount (USD)
13,604,000
Latest Funding Round Date
January 2022
Stock Symbol
BRAX
Exchange
Former CEO
Also Known As
Braxia Scientific
Latest Funding Type
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
2,267,000
Champignon is pursuing the development and marketing of rapid onset treatments capable of improving health outcomes such as depression and post-traumatic stress disorder (PTSD), as well as disorders related to substance and alcohol use.
Holdings
The company's brand holdings include:
- AltMed, a provider of psychedelic medicine clinical services and conductor of clinical trials
- Tassili Life Sciences Corp., which conducts R&D and clinical trials
- Novo Formulations, which develops psychedelic formulations and delivery systems
- Artisan Growers, which performs research into psilocybin and psilocybe mushrooms
- Vitality Superteas, mushroom-derived consumer packaged goods
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.